The irregular use of antiretroviral therapy (ART) can result in ART-resistance but can also lead to a sensitization between agents with a cross-sensitivity. We report a case of nevirapine-associated toxic epidermal necrolysis resulting in death in an HIV-infected man.
FagotJP, MockenhauptM, Bouwes-BavinckJN.Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.AIDS2001; 15: 1843–8.
2.
KongHH, MyersSA.Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.Dermatol Ther2005; 18: 58–66.
3.
GatanagaH, YazakiH, TanumaJ.HLA-Cw8 primarily associated with hypersensitivity to nevirapine.AIDS2007; 21: 264–5.
4.
van LethF, PhanuphakP, RuxrungthamK.Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study.Lancet2004; 363: 1253–63.
5.
RotundaA, HirschRJ, ScheinfeldN, WeinbergJM.Severe cutaneous reactions associated with the use of human immunodeficiency virus medications.Acta Derm Venereol2003; 83: 1–9.
6.
MetryDW, LahartCJ, FarmerKL, HebertAA.Stevens-Johnson syndrome caused by the antiretroviral drug nevirapine.J Am Acad Dermatol2001; 44: 354–7.
7.
NordstromBL, NormanHS, DubeTJ, WilcoxMA, WalkerAM.Identification of abacavir hypersensitivity reaction in health care claims data.Pharmacoepidemiol Drug Saf2007; 16: 289–96.
